In CRC, exosomes from tumor cells, rich in circular RNAs, activate TAMs’ NF-κB pathway, leading to IL-6 secretion and triggering tumor cells’ Janus kinase 2 (Jak2)/STAT3 pathway. The gene discussed is IL6; the disease is neoplasm.